10 years before malaria vaccine is ready for widespread use
Apr 28, 2005, 18:35, Reviewed by: Dr.
|
|
"Malaria vaccine research has progressed rapidly over the past few years, helped by the availability more funds and by improved organisation mediated through organisations such as the Malaria Vaccine Initiative. However, it is likely to be at least a decade before an efficacious vaccine is available for widespread use in malaria-endemic countries."
|
By THE LANCET,
A seminar on malaria in this week's issue of THE LANCET states that it will be at least a decade before a vaccine for the disease will be ready for widespread use and emphasises the need to expand the use of existing control methods.
Brian Greenwood (London School of Hygiene and Tropical Medicine, UK) and colleagues state that prevention and treatment of malaria could be greatly improved with existing methods if increased financial and labour resources were available. Combination therapies based on drugs derived from the plant Artemisia annua (ACTs) have now been adopted by many endemic countries, although cost is likely to be a problem in ensuring their widespread use. ACTs are highly effective, even in areas where there is a high level of resistance to other antimalarial drugs. (See this week's issue Lancet 365; 1467-73, Lancet 365; 1474-1480) Insecticide-treated bed-nets provide a simple but effective means of preventing malaria, especially with the development of longlasting nets in which insecticide is incorporated into net fibres and is not removed during washing.
However, the authors state that new approaches to prevention and treatment are needed including malaria vaccines. One malaria vaccine, RTS, S/AS02 has provided substantial, short-lived protection in volunteers exposed experimentally to bites by infected mosquitoes and in semi-immune adults in The Gambia exposed to natural infection. (See Lancet 2001; 358: 1927-34) In a subsequent trial in Mozambican children, the RTS, S/AS02 vaccine gave 30% protection against the first clinical episode of malaria and 58% protection against severe malaria. (See Lancet 2004; 364: 1411-20) Other promising candidates are undergoing clinical trials.
Professor Greenwood states: "Malaria vaccine research has progressed rapidly over the past few years, helped by the availability more funds and by improved organisation mediated through organisations such as the Malaria Vaccine Initiative. However, it is likely to be at least a decade before an efficacious vaccine is available for widespread use in malaria-endemic countries." 
- Professor Brian M Greenwood, Department of Medical Parasitology, London School of Hygiene & Tropical Med, 50 Bedford Square, London WC1B 3DP, UK. T) 020 7299 4707 [email protected]
www.thelancet.com
A public health article about malaria control in Afghanistan published online last year appears in this week's print issue.
The fifth Africa Malaria Day is on April 25, 2005. Africa Malaria Day marks the anniversary of the Abuja Declaration of 2000, in which the Heads of State or their senior representatives from 44 African countries pledged to halve malaria mortality by 2010.
|
For any corrections of factual information, to contact the editors or to send
any medical news or health news press releases, use
feedback form
Top of Page
|
